Please login to the form below

Not currently logged in
Email:
Password:

The Grey Healthcare Group Award for Excellence in Health Improvement and Education

Sponsored by

Finalist

Think Test for HIV

Bristol-Myers Squibb in association with Mash Health


Summary of work

Late diagnosis of HIV remains an issue in the UK, affecting morbidity and mortality. While guidelines set out criteria for testing outside the genitourinary medicine (GUM) setting, testing in other specialties remains low. 

We worked with Bristol-Myers Squibb to develop a programme designed to increase HIV testing in non-GUM Secondary Care settings. In the 10 months since launch, the ‘Think Test for HIV’ initiative has been adopted in more than 38 hospitals. In one hospital, this has already resulted in a 60 per cent increase in HIV testing and a 13 per cent increase in early diagnosis – directly impacting on patients’ lives.

 

 

Executive summary as submitted


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics